Moreover, data manifested that hepatic AMOTL2 expression level in NASH group animals was significantly decreased (P < 0.001), in comparison to NC and was significantly corrected by Kefir administration. This evidence concerns the gene AMOTL2 and metabolic dysfunction-associated steatohepatitis.